NCT02228746

Effect of the Alpha-galacto-oligasaccharides on Weight Loss in Overweight or Moderately Obeses Adults : A Randomized Controlled Double Blinded Trial Versus Placebo

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Olygose · Industry
• Sex: All
• Age: 20 Years – 70 Years
• Healthy volunteers: Accepted

Summary

Clinical intervention on overweight or moderately obeses adults. The objective of this trial is to demonstrate the superior eficacy of Alphagos to placebo on weight loss during a low-calorie diet of 12 weeks. The superiority is judged on body weight. Change in cardiometabolic risk factors through the intervention have been evaluated as secondary endpoints

Conditions

• Randomized Versus Placebo
• Controlled
• Double Blind

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Alpha-galacto-oligosaccharides	6g of alpha-galacto-oligosaccharides in a 100 mL flavored drink

Timeline

• Start date: 2013-09-01
• Primary completion: 2014-08-01
• Completion: 2014-08-01
• First posted: 2014-08-29
• Last updated: 2014-08-29

Locations

1 site across 1 country: France